Meghan C. Thompson

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 16 papers. Top paper: “COVID-19 in patients with CLL: improved survival outcomes and update on management strategies”.

COVID-19 in patients with CLL: improved survival outcomes and update on management strategies

Blood(2021)10.1182/blood.2021011841

N/A

3.5DataRank · unranked

70 citations

Toby A. Eyre, Meghan C. Thompson, Nicole Lamanna, Alexander Coltoff, Matthew S. Davids +47 more

Anti-SARS-CoV-2 antibody response in patients with chronic lymphocytic leukemia

Leukemia(2020)10.1038/s41375-020-01030-2

N/A

0.705DataRank · unranked

109 citations

David A. Knorr, Melissa S. Pessin, Lakshmi V. Ramanathan, Meghan C. Thompson, Lori A. Leslie +3 more

Universal germline genetic testing in patients with hematologic malignancies using DNA isolated from nail clippings

Haematologica(2024)10.3324/haematol.2024.285055

N/A

0.360DataRank · unranked

10 citations

Elise Fiala, Satshil Rana, Margaret Sheehan, Jennifer A. Kennedy, Zarina Yelskaya +40 more

Outcomes of relapsed or refractory acute myeloid leukemia after menin inhibition failure

Blood Advances(2025)10.1182/bloodadvances.2025018178

N/A

0.357DataRank · unranked

7 citations

Brian Ball, Yasmin Abaza, Jessica K. Altman, Rahul Thakur, Moiez Ali +12 more

BTK Inhibitors Versus Venetoclax as First‐ or Second‐Line Therapy in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Real‐World Evidence Study

American Journal of Hematology(2025)10.1002/ajh.27639

N/A

0.165DataRank · unranked

2 citations

Yi Han, Anna Teschemaker, Anthony R. Mato, Meghan C. Thompson, Lindsey E. Roeker

Safety of Extended Pirtobrutinib Exposure in Relapsed and/or Refractory B-Cell Malignancies

Acta Haematologica(2024)10.1159/000539587

N/A

0.104DataRank · unranked

1 citations

Catherine C. Coombs, Nirav N. Shah, Wojciech Jurczak, Jennifer A. Woyach, Chan Y. Cheah +16 more

Kinase-impaired BTK mutations are susceptible to clinical-stage BTK and IKZF1/3 degrader NX-2127

Science(2024)10.1126/science.adi5798

N/A

0DataRank · unranked

152 citations

Jessie Bourcier, Mark Noviski, Hao Lu, Meghan C. Thompson, Alexandra Chirino +48 more

Pirtobrutinib monotherapy in Bruton tyrosine kinase inhibitor-intolerant patients with B-cell malignancies: results of the phase I/II BRUIN trial

Haematologica(2024)10.3324/haematol.2024.285754

N/A

0DataRank · unranked

13 citations

Michael Wang, Lindsey E. Roeker, Krish Patel, Jennifer A. Woyach, William G. Wierda +30 more

Outcomes of patients with Richter transformation who received no prior chemoimmunotherapy for their CLL

Blood Cancer Journal(2025)10.1038/s41408-025-01236-6

N/A

0DataRank · unranked

12 citations

Ying Huang, Sarah Miller, John N. Allan, Seema A. Bhat, David A. Bond +40 more

Outpatient cytarabine consolidation in acute myeloid leukemia safely reduces hospitalization time and treatment costs

Cancer(2025)10.1002/cncr.70024

N/A

0DataRank · unranked

3 citations

Leora Boussi, David Nemirovsky, Andriy Derkach, Jenna Ciervo, Christopher Famulare +12 more

Management of Relapsed and/or Refractory Chronic Lymphocytic Leukemia

Hematology/Oncology Clinics of North America(2025)10.1016/j.hoc.2025.05.008

N/A

0DataRank · unranked

1 citations

Meghan C. Thompson, Allison Kagerer

COVID-19 vaccine efficacy in patients with chronic lymphocytic leukemia

Leukemia(2021)10.1038/s41375-021-01270-w

N/A

0DataRank · unranked

156 citations

David A. Knorr, Meghan C. Thompson, Mariely Nivar, Sonia Lebowitz, Nicole V. Peters +13 more

Adding Umbralisib and Ublituximab (U2) to Ibrutinib in Patients with CLL: A Phase II Study of an MRD-Driven Approach

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-0964

N/A

0DataRank · unranked

13 citations

Tatyana Feldman, Jacob D. Soumerai, Victoria Falco, Gail Panton, Colleen Dorsey +21 more

Data from Adding Umbralisib and Ublituximab (U2) to Ibrutinib in Patients with CLL: A Phase II Study of an MRD-Driven Approach

(2023)10.1158/1078-0432.c.6532596

N/A

0DataRank · unranked

0 citations

Tatyana Feldman, Jacob D. Soumerai, Victoria Falco, Gail Panton, Colleen Dorsey +21 more

Data from Adding Umbralisib and Ublituximab (U2) to Ibrutinib in Patients with CLL: A Phase II Study of an MRD-Driven Approach

(2023)10.1158/1078-0432.c.6532596.v1

N/A

0DataRank · unranked

0 citations

Tatyana Feldman, Jacob D. Soumerai, Victoria Falco, Gail Panton, Colleen Dorsey +21 more

Novel identification of t(14;18)(q32;q21)/IGH::MALT1 in chronic lymphocytic leukaemia

British Journal of Haematology(2023)10.1111/bjh.19235

N/A

0DataRank · unranked

0 citations

Mark D. Ewalt, Yanming Zhang, JinJuan Yao, Meghan C. Thompson, Ahmet Doǧan +1 more